EP3485890
SGLT2 INHIBITORS FOR TREATMENT OF METABOLIC DISORDERS IN CANINE ANIMALS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
20.1.2015EP published:
10.5.2023EP application number:
18208143.0
EPO information:
European Patent Register
Max expiry date:
19.1.2035
Title in English:
SGLT2 INHIBITORS FOR TREATMENT OF METABOLIC DISORDERS IN CANINE ANIMALSLanguage of the patent:
English
Timeline
Today
20.1.2015EP application
10.5.2023EP Publication
Owner
Name:
Boehringer Ingelheim Vetmedica GmbHAddress:
Binger Strasse 173, 55216 Ingelheim am Rhein, DE
Inventor
Name:
REICHE, Dania BirteAddress:
55216 INGELHEIM AM RHEIN, DE
Name:
KLEY, SaskiaAddress:
55216 INGELHEIM AM RHEIN, DE
Priority
Number:
14152327Date:
23.1.2014Country:
EP
Number:
14186477Date:
25.9.2014Country:
EP
Classification
Categories:
A61K 31/7034, A61P 3/06, A61P 3/10, A61K 9/02, A61K 9/08, A61K 9/20, A61K 9/48, A61K 38/28, A61K 45/06, A61K 31/00, A61P 1/16, A61P 1/18, A61P 13/12, A61P 19/00, A61P 21/00, A61P 27/02, A61P 27/12, A61P 29/00, A61P 3/00